Opinion statement
Kleine-Levin Syndrome [KLS] is often under-recognized and also misdiagnosed. When suspicion for KLS is raised, a thorough clinical evaluation should be performed, including detailed history from family members and a neurologic and psychiatric examination. Additional studies may include PSG, EEG, neuroimaging, as well as serological and CSF studies to rule out alternative diagnoses as clinically indicated. After arriving at a diagnosis of KLS, the foundation of care is supportive. Patients and their families should be provided with education about the disease. During symptomatic periods, patients should be allowed to rest at home under caregiver supervision. Caregivers should pay special attention to the patient’s eating habits and mood. Patients should not be allowed to drive or operate heavy machinery during these episodes. In between episodes, avoidance of reported triggers, such as alcohol and infection are encouraged as is maintenance of a regular sleep-wake cycle. Pharmacologic therapy has not been well-studied and for most patients is not necessary. For more severe cases, targeted symptomatic therapy, such as modafinil or amantadine for somnolence or risperidone for psychosis may be considered depending on the patient’s symptomatology. Lithium has the best data to support its use as a prophylactic agent and for patients with severe or frequent episodes, may be considered.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance
Chauvot de Beauchêne E. Observation sur une maladie nerveuse, avec complication d’un sommeil, tantôt léthargique, tantôt convulsif. Méquignon aîné, A Amsterdam et à Paris. 1786.
Walusinski O. Observation of a nervous disease attended by disturbed sleep, at times lethargic and at times convulsive. Edmé Chauvot de Beauchêne (1786). J Neurol Neurosurg Psychiatry. 2007;78:975–6. doi:10.1136/jnnp.2007.120758.
Kleine W. Periodische Schlafsucht. Eur Neurol. 1925;57:285–304. doi:10.1159/000190426.
Critchley M, Hoffman HL. The syndrome of period somnolence and morbid hunger (Kleine-Levin syndrome). Br Med J. 1942;1:137–9.
American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL. 2014. This provides updated diagnostic criteria from the AASM for KLS and other sleep disorders. Of note, it replaces recurrent hypersomnia with KLS instead of considering KLS as a subtype of recurrent hypersomnia.
Lavault S, Golmard J-L, Groos E, et al. Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol. 2015;77:529–40. doi:10.1002/ana.24350.
Arnulf I. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain. 2005;128:2763–76. doi:10.1093/brain/awh620.
Arnulf I, Lin L, Gadoth N, et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol. 2008;63:482–93. doi:10.1002/ana.21333.
Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11:918–28. doi:10.1016/S1474-4422(12)70187-4.
Ueno T, Fukuhara A, Ikegami A, et al. Monozygotic twins concordant for Kleine-Levin syndrome. BMC Neurol. 2012;12:31. doi:10.1186/1471-2377-12-31.
Peraita-Adrados R, Vicario JL, Tafti M, et al. Monozygotic twins affected with Kleine-Levin syndrome. Sleep. 2012;35:595–6. doi:10.5665/sleep.1808.
Engström M, Vigren P, Karlsson T, Landtblom A-M. Working memory in 8 Kleine-Levin syndrome patients: an fMRI study. Sleep. 2009;32:681–8.
Körtner K, Hansen ML, Danker-Hopfe H, et al. Persistent deficits of visual recall in Kleine-Levin syndrome. J Clin Neurosci. 2011;18:439–40. doi:10.1016/j.jocn.2010.07.105.
Miglis MG, Guilleminault C. Kleine-Levin syndrome: a review. Nat Sci Sleep. 2014;6:19–26. doi:10.2147/NSS.S44750. This review article provides a broad update on the status of KLS.
Landtblom A, Dige N. Short-term memory dysfunction in Kleine–Levin syndrome. Acta Neurol Scand. 2003;108:363–7. doi:10.1046/j.1600-0404.2003.00171.x.
Arnulf I. Kleine-Levin syndrome. Sleep Med Clin. 2015;10:151–61. doi:10.1016/j.jsmc.2015.02.001. This review article provides a broad update on the status of KLS.
Huang Y-S, Guilleminault C, Lin K-L, et al. Relationship between Kleine-Levin syndrome and upper respiratory infection in Taiwan. Sleep. 2012. doi:10.5665/sleep.1600.
Kornum BR, Rico T, Lin L, et al. Serum cytokine levels in Kleine–Levin syndrome. Sleep Med. 2015;16:961–5. doi:10.1016/j.sleep.2015.02.540.
Lopez R, Barateau L, Chenini S, Dauvilliers Y. Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine–Levin syndrome. Sleep Med. 2015;16:194–6. doi:10.1016/j.sleep.2014.07.022.
Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74:1667–73. doi:10.1136/jnnp.74.12.1667.
Cho JW, Kim JH (2015) Recurrent hypersomnia in an 18-year old boy: CSF hypocretin level and MSLT findings. Sleep Med 9457. doi: 10.1016/j.sleep.2015.07.007.
Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59:1739–45. doi:10.1212/01.WNL.0000036605.89977.D0.
Huang Y, Lin Y-H, Guilleminault C. Polysomnography in Kleine-Levin syndrome. Neurology. 2008;70:795–801. doi:10.1212/01.wnl.0000304133.00875.2b.
Vigren P, Engström M, Landtblom A-M. SPECT in the Kleine-Levin syndrome, a possible diagnostic and prognostic aid? Front Neurol. 2014;5:5–8. doi:10.3389/fneur.2014.00178.
Engström M, Karlsson T, Landtblom A-M. Thalamic activation in the Kleine-Levin syndrome. Sleep. 2014;37:379–86. doi:10.5665/sleep.3420.
Engström M, Hallböök T, Szakacs A, et al. Functional magnetic resonance imaging in narcolepsy and the Kleine-Levin syndrome. Front Neurol. 2014;5:1–6. doi:10.3389/fneur.2014.00105.
Kas A, Lavault S, Habert M-O, Arnulf I. Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome. Brain. 2014;137:2077–87. doi:10.1093/brain/awu112.
Huang Y-S, Guilleminault C, Kao P-F, Liu F-Y. SPECT findings in the Kleine-Levin syndrome. Sleep. 2005;28:955–60.
Koerber RK, Torkelson R, Haven G, et al. Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome. Neurology. 1984;34:1597–600.
Carpenter S, Yassa R, Ochs R. A pathologic basis for Kleine-Levin syndrome. Arch Neurol. 1982;39:25–8.
Fenzi F, Simonati A, Crosato F, et al. Clinical features of Kleine-Levin syndrome with localized encephalitis. Neuropediatrics. 1993;24:292–5. doi:10.1055/s-2008-1071559.
Takrani LB, Cronin D. Kleine-Levin syndrome in a female patient. Can Psychiatr Assoc J. 1976;21:315–8.
Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev. 2013;8:CD006685. doi:10.1002/14651858.CD006685.pub3.
Leu-Semenescu S, Le Corvec T, Groos E, et al. Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients. Neurology. 2015. doi:10.1212/WNL.0000000000002104. This study represents the largest and first controlled trial of any medication used for treatment of KLS and raises promise for the use of lithium in this disorder.
Crumley FE. Valproic acid for Kleine-Levin syndrome. J Am Acad Child Adolesc Psychiatry. 1997;36:868–9. doi:10.1097/00004583-199707000-00005.
Adlakha A, Chokroverty S. An adult onset patient with Kleine-Levin syndrome responding to valproate. Sleep Med. 2009;10:391–3. doi:10.1016/j.sleep.2008.07.006.
Perin BV, Rodrigues I, Giasson FTB, et al. Recurrent hypersomnia: report of medication-responsive cases. Sleep Sci. 2015;8:100–2. doi:10.1016/j.slsci.2015.06.003.
El Hajj T, Nasreddine W, Korri H, et al. A case of Kleine-Levin syndrome with a complete and sustained response to carbamazepine. Epilepsy Behav. 2009;15:391–2. doi:10.1016/j.yebeh.2009.05.005.
Surges R, Walker MC. A case of late-onset Kleine-Levin syndrome responding to lamotrigine. Sleep Med. 2009;10:394. doi:10.1016/j.sleep.2008.03.001.
Aggarwal A, Garg A, Jiloha RC. Kleine-Levine syndrome in an adolescent female and response to modafinil. Ann Indian Acad Neurol. 2011;14:50–2. doi:10.4103/0972-2327.78052.
Mignot EJM. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9:739–52. doi:10.1007/s13311-012-0150-9.
Trotti LM, Bliwise DL, Rye DB. Further experience using clarithromycin in patients with Kleine-Levin syndrome. J Clin Sleep Med. 2014;10:457–8. doi:10.5664/jcsm.3634.
Rezvanian E, Watson NF. Kleine-Levin syndrome treated with clarithromycin. J Clin Sleep Med. 2013;9:1211–2. doi:10.5664/jcsm.3176.
Kapson B, Nayar S, Spiegel R. Treatment of Kleine-Levin syndrome with Acetazolamide. 2014;10:3–4.
Ortega-Albás JJ, Díaz JR, López-Bernabé R, et al. Treatment of Kleine-Levin syndrome with sodium oxybate. Sleep Med. 2011;12:730. doi:10.1016/j.sleep.2011.06.001.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Oliver Sum-Ping and Christian Guilleminault declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Sleep Disorders
Rights and permissions
About this article
Cite this article
Sum-Ping, O., Guilleminault, C. Kleine-Levin Syndrome. Curr Treat Options Neurol 18, 24 (2016). https://doi.org/10.1007/s11940-016-0409-2
Published:
DOI: https://doi.org/10.1007/s11940-016-0409-2